Avenue Therapeutics Announces Participation in Investor Conferences
Avenue Therapeutics Announces Upcoming Investor Engagements
MIAMI, Sept. 03, 2024 — Avenue Therapeutics, Inc. (Nasdaq: ATXI) is gearing up for several important upcoming investor conferences. This initiative highlights Avenue's commitment to advancing treatments for neurologic diseases. Alexandra MacLean, M.D., the company's Chief Executive Officer, will be representing Avenue at these notable events.
Key Conference Details
Avenue Therapeutics will participate in:
H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9, 2024
Format: Company Presentation and 1x1 Meetings
Lake Street Capital Markets BIG8 Conference
Date: September 12, 2024
Format: 1x1 Meetings
The presentation at the H.C. Wainwright conference will be available for on-demand viewing starting at 7:00 a.m. ET on September 9, 2024. This presents an excellent opportunity for investors to gain insights into Avenue Therapeutics' innovative research and strategic direction.
About Avenue Therapeutics
Avenue Therapeutics, Inc. (Nasdaq: ATXI) is a specialized pharmaceutical company committed to the development and commercialization of advanced therapies for neurologic conditions. The company is currently focusing on three significant projects: AJ201, aimed at treating spinal and bulbar muscular atrophy; BAER-101, a selective GABAA ?2, ?3 receptor positive allosteric modulator designed for central nervous system diseases; and IV tramadol, which is intended for acute postoperative pain management in medically supervised environments.
Founded by Fortress Biotech, Inc. (Nasdaq: FBIO), Avenue Therapeutics is strategically headquartered in Miami, FL. Their innovative approach and dedication to improving patient care sets them apart in the pharmaceutical landscape.
Contact Information
For further inquiries, please reach out to Jaclyn Jaffe at Avenue Therapeutics, Inc. You can contact her at (781) 652-4500 or via email at ir@avenuetx.com.
Frequently Asked Questions
What is Avenue Therapeutics focused on?
Avenue Therapeutics specializes in developing therapies for neurologic diseases, with a strong emphasis on innovative treatment methods.
Who will represent Avenue at the upcoming conferences?
Alexandra MacLean, M.D., the CEO of Avenue Therapeutics, will represent the company at these events.
What are the dates for the investor conferences?
The H.C. Wainwright conference occurs on September 9, 2024, and the Lake Street Capital Markets conference takes place on September 12, 2024.
How can I contact Avenue Therapeutics for more information?
For inquiries, you may contact Jaclyn Jaffe at (781) 652-4500 or via email at ir@avenuetx.com.
What innovative projects is Avenue Therapeutics working on?
They are developing AJ201, BAER-101, and IV tramadol, each targeting different aspects of neurologic conditions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Super Micro Computer Responds to Hindenburg's Allegations
- Leinco Technologies Inc. Expands Portfolio with QED Biosciences
- Jamie Foxx Brings Humor to BetMGM's 2024 Football Campaign
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Exdion Insurance Unveils CSRdigit: Revolutionizing E&O Protection
- Sippable Delight: Baileys Cinnamon Churros Cream Liqueur
- Investing Insights: Nvidia Versus Arm Holdings in AI Sector
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- BoomerangFX Expands Innovative Solutions in Asia and Latin America
- Trethom AS Reduces Major Shareholding in Vow ASA Below 5%
- Supermicro Addresses Concerns Over Annual Report Filing
- Bloomberg CityLab 2024: Global Mayors Gather in Mexico City
- Cork Packaging Market Expected to Hit USD 2.7 Billion Growth
- MICE Industry Expected to Reach $1,337 Billion by 2033
- Packaging Automation Market Growth Driven by E-commerce Boom
- CapexMD Welcomes Alex Shire as New CEO in Exciting Shift
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Ethical AI Transformation: The P&C Insurance Industry's Role
- Innovative Wireless Charging Technology Utilizing RF Signals
- Aker ASA Finalizes Aker BioMarine Feed Ingredients Deal
- Fuel for a Cause: Peninsula Bridge Partners with Shell and Loop
- Concord Acquisition Corp II Considers Nasdaq Listing Following Delisting
- Exploring the Event Logistics Market Growth to USD 87.8 Billion
- Scot Cave Appointed Field Veterinary Manager at PetVivo Holdings
- Middlefield Canadian Income PCC: Major Holdings Update
Recent Articles
- Innovative Wireless Charging Technology Utilizing RF Signals
- Exploring the Event Logistics Market Growth to USD 87.8 Billion
- Education ERP Market Growth Projected to USD 75.84 Billion
- Constellation Brands Adjusts Earnings Outlook for 2025
- Exploring the Projected Growth of the Augmented Analytics Market
- Elliott Wave Insights on the Nikkei 225's Market Movement
- Object Management Group Launches New Journal of Innovation
- Affiliated Network Providers and Aurora Health Join Forces
- Christian Lingua Earns Top Language Training Honor in Industry
- Lake City Bank Enhances Warsaw Campus with New Center
- Smart Elevator Market Expected to Reach $43.91 Billion by 2031
- Mount Logan Capital Inc. Expands Workforce with New Hire
- Callinex Begins 2024 Exploration at Pine Bay Project Initiative
- GEN3 Silicon-Anode Batteries Surpass Graphite by 40% Capacity
- Protara Therapeutics to Showcase Innovations at H.C. Wainwright Conference
- NRx Pharmaceuticals and HOPE Therapeutics to Present at Conference
- US Stock Futures Drop as Labor Data Week Begins
- Green Bonds Market Expected to Reach $960 Billion by 2033
- NCL Corporation Ltd. Proposes Offering of Senior Notes
- Axxess and Transcend Strategy Group Collaborate for Growth
- BeyondSpring Set to Present Key Findings at Major Global Events
- PolyPid Announces Participation in Key Fall Investor Events
- Eyenovia Appoints Andrew Jones as Chief Financial Officer
- Quantum Cascade Laser Market Growth and Future Prospects
- REMSleep Secures Patent Approval for Nasal Ventilation System